MARLYS BITNER: Open Payments
NPI 1528172095 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 47 payments from 14 companies in 2025. Trend: 2023 $2,294 · 2024 $809 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $218 |
| Amgen Inc. | 8 | $195 |
| Alnylam Pharmaceuticals Inc. | 5 | $164 |
| Actelion Pharmaceuticals US, Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| BridgeBio Pharma, Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| CVRx, Inc. | 2 | $26 |
Products named: VYNDAQEL, REPATHA, AMVUTTRA, ELIQUIS, WAINUA, UPTRAVI, VERQUVO, Attruby.
Industry payments across AR — which companies pay providers there.
